El extracto proteico de la sanguijuela Poecilobdella manillensis mejoró la hiperuricemia al corregir la desregulación de la microbiota intestinal y afectar a los metabolitos séricos

BACKGROUND: Hyperuricemia (HUA) is a public health concern that needs to be solved urgently. The lyophilized powder of Poecilobdella manillensis has been shown to significantly alleviate HUA; however, its underlying metabolic regulation remains unclear. AIM: To explore the underlying mechanisms of Poecilobdella manillensis in HUA based on modulation of the gut microbiota and host metabolism. METHODS: A mouse model of rapid HUA was established using a high-purine diet and potassium oxonate injections. The mice received oral drugs or saline. Additionally, 16S rRNA sequencing and ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry-based untargeted metabolomics were performed to identify changes in the microbiome and host metabolome, respectively. The levels of uric acid transporters and epithelial tight junction proteins in the renal and intestinal tissues were analyzed using an enzyme-linked immunosorbent assay. RESULTS: The protein extract of Poecilobdella manillensis lyophilized powder (49 mg/kg) showed an enhanced anti-trioxypurine ability than that of allopurinol (5 mg/kg) (P < 0.05). A total of nine bacterial genera were identified to be closely related to the anti-trioxypurine activity of Poecilobdella manillensis powder, which included the genera of Prevotella, Delftia, Dialister, Akkermansia, Lactococcus, Escherichia_Shigella, Enterococcus, and Bacteroides. Furthermore, 22 metabolites in the serum were found to be closely related to the anti-trioxypurine activity of Poecilobdella manillensis powder, which correlated to the Kyoto Encyclopedia of Genes and Genomes pathways of cysteine and methionine metabolism, sphingolipid metabolism, galactose metabolism, and phenylalanine, tyrosine, and tryptophan biosynthesis. Correlation analysis found that changes in the gut microbiota were significantly related to these metabolites. CONCLUSION: The proteins in Poecilobdella manillensis powder were effective for HUA. Mechanistically, they are associated with improvements in gut microbiota dysbiosis and the regulation of sphingolipid and galactose metabolism.

Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.

El resumen se deja sin traducir para conservar la redacción original de los autores.

En un modelo murino de hiperuricemia rápida (dieta rica en purinas y oxonato potásico), el extracto proteico de Poecilobdella manillensis (49 mg/kg) resultó más eficaz que alopurinol (5 mg/kg) (P < 0,05). La secuenciación del ARNr 16S y la metabolómica vincularon al efecto nueve géneros bacterianos y 22 metabolitos séricos. Los autores concluyen que las proteínas fueron eficaces y se asocian con una mejora de la disbiosis intestinal y con la regulación del metabolismo de esfingolípidos y galactosa.

Explore cómo esta investigación se conecta con la práctica clínica

Más estudios revisados por pares en la categoría «Farmacología salival».

• Sanguijuelas medicinales e hirudoterapia — Gödekmerdan A et al. (2011)
• Peroxidación de lípidos salivales en pacientes con síndrome poscovid durante la hirudoterapia — Serikbayeva S et al. (2024)
• Terapia con sanguijuelas medicinales en síndromes dolorosos: una revisión narrativa — Koeppen D, Aurich M, Rampp T (2014)
• Efectos inmunomoduladores del extracto de saliva de la sanguijuela medicinal sobre macrófagos activados in vitro — Ayhan H et al. (2024)
• Inhibidores de proteinasas de la sanguijuela medicinal Hirudo medicinalis — Baskova I, Zavalova L (2001)
• Polifuncionalidad de la destabilasa, una lisozima de una sanguijuela medicinal — Baskova I, Zavalova L (2008)
• Hazlo doble: identificación y caracterización de una hirudina en tándem de la sanguijuela medicinal asiática Hirudinaria manillensis — Lukas P et al. (2022)
• Use of the medicinal leech in the treatment of ear diseases — Seleznev K et al. (1992)
• La destabilasa recombinante de Hirudo medicinalis puede disolver coágulos sanguíneos humanos in vitro — Bobrovsky P et al. (2021)
• Efectos de la dispersión ambiental de nanotubos de carbono sobre un invertebrado acuático, Hirudo medicinalis — Girardello R et al. (2015)

Ver toda la investigación analizada por la ASH →